[Effects of complex therapy with emoxipin on the course of diabetic retinopathy].
The efficacy of 1% emoxipin solution (eye drops) in the nonproliferative stage of diabetic retinopathy was studied. The inhibition of lipid peroxidation and an enhancement of antioxidizing guard were observed both after the therapy by the above preparation and 3 months later. It was concluded that emoxipin was effective for leveling the biochemical violations in the "lipid peroxidation--antioxidants" system of lachrymal fluid in patients with the nonproliferative stage of diabetic retinopathy. The prescription of emoxipin eye drops can enhance the efficacy of therapy at the early stages of the disease.
D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism; D003930:Diabetic Retinopathy / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D005500:Follow-Up Studies; D006801:Humans; D015227:Lipid Peroxidation; D008875:Middle Aged; D009883:Ophthalmic Solutions; D009887:Ophthalmoscopy; D010847:Picolines / Q000008:administration & dosage / Q000627:therapeutic use*; D013666:Tears / Q000378:metabolism; D013997:Time Factors
D000975:Antioxidants; D009883:Ophthalmic Solutions; D010847:Picolines; C009820:6-methyl-2-ethyl-3-hydroxypyridine
Vliianie kompleksnoĭ terapii s émoksipinom na techenie diabeticheskoĭ retinopatiĭ.